| Year |
Citation |
Score |
| 2024 |
Shi W, Xu G, Gao Y, Yang H, Liu T, Zhao J, Li H, Wei Z, Hou X, Chen Y, Wen J, Li C, Zhao J, Zhang P, Wang Z, et al. Compound Danshen Dripping Pill effectively alleviates cGAS-STING-triggered diseases by disrupting STING-TBK1 interaction. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 128: 155404. PMID 38507852 DOI: 10.1016/j.phymed.2024.155404 |
0.303 |
|
| 2023 |
Zhou J, Xie Z, Wang J, Zeng Z, Hu Z, Zhong L, Yang Q, Shi W, Qian H. Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors. European Journal of Medicinal Chemistry. 264: 116032. PMID 38104378 DOI: 10.1016/j.ejmech.2023.116032 |
0.323 |
|
| 2023 |
Tao S, Yang EJ, Zong G, Mou PK, Ren G, Pu Y, Chen L, Kwon HJ, Zhou J, Hu Z, Khosravi A, Zhang Q, Du Y, Shi WQ, Shim JS. ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones. International Journal of Biological Sciences. 19: 4020-4035. PMID 37705743 DOI: 10.7150/ijbs.82012 |
0.545 |
|
| 2023 |
Harris TJ, Liao Y, Shi W, Evangelista M, Pal B, Puthalakath H, Aston R, Mollard R, Mariadason JM, Lee EF, Fairlie WD. Induction of endoplasmic reticulum stress is associated with the anti-tumor activity of monepantel across cancer types. Cancer Medicine. PMID 37148543 DOI: 10.1002/cam4.6021 |
0.321 |
|
| 2023 |
Qiu Q, Chi F, Zhou D, Xie Z, Liu Y, Wu H, Yin Z, Shi W, Qian H. Exploration of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Bispecific Inhibitors Based on the Moiety of Fedratinib for Treatment of Both Hematologic Malignancies and Solid Cancers. Journal of Medicinal Chemistry. PMID 37057760 DOI: 10.1021/acs.jmedchem.3c00036 |
0.312 |
|
| 2023 |
Liu F, Wang B, Liu Y, Shi W, Hu Z, Chang X, Tang X, Zhang Y, Xu H, He Y. Design, synthesis and biological evaluation of novel N-(methyl-d) pyridazine-3-carboxamide derivatives as TYK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 86: 129235. PMID 36907336 DOI: 10.1016/j.bmcl.2023.129235 |
0.349 |
|
| 2022 |
Ren J, Gao Y, Shi W, Xu S, Wang Q, Zhao D, Kong L, Song W, Wang X, Zhang Y, He X, Wang Y, Tong S, Lu P, Li Y, et al. Design and synthesis of boron-containing ALK inhibitor with favorable in vivo efficacy. Bioorganic & Medicinal Chemistry. 75: 117071. PMID 36332597 DOI: 10.1016/j.bmc.2022.117071 |
0.333 |
|
| 2022 |
Li H, Wang Y, Lin K, Venkadakrishnan VB, Bakht M, Shi W, Meng C, Zhang J, Tremble K, Liang X, Song JH, Feng X, Van V, Deng P, Burks JK, et al. CHD1 promotes sensitivity to Aurora kinase inhibitors by suppressing interaction of AURKA with its coactivator TPX2. Cancer Research. PMID 35771632 DOI: 10.1158/0008-5472.CAN-22-0631 |
0.301 |
|
| 2022 |
Wang Q, Hu X, Shi W, Long H, Wang H. Design, synthesis and biological evaluation of chromone derivatives as novel protein kinase CK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 69: 128799. PMID 35580724 DOI: 10.1016/j.bmcl.2022.128799 |
0.34 |
|
| 2022 |
Shi W, Feng Z, Chi F, Zhou J, Qiu Q, Jiang Y, Chen S, Zhong Y, Jia H, Huang W, Qian H. Structure-based discovery of receptor tyrosine kinase AXL degraders with excellent anti-tumor activity by selectively degrading AXL and inducing methuosis. European Journal of Medicinal Chemistry. 234: 114253. PMID 35279611 DOI: 10.1016/j.ejmech.2022.114253 |
0.346 |
|
| 2021 |
Li Q, Feng H, Wang H, Wang Y, Mou W, Xu G, Zhang P, Li R, Shi W, Wang Z, Fang Z, Ren L, Wang Y, Lin L, Hou X, et al. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction. Embo Reports. e53499. PMID 34882936 DOI: 10.15252/embr.202153499 |
0.336 |
|
| 2021 |
Shi W, Men L, Pi X, Jiang T, Peng D, Huo S, Luo P, Wang M, Guo J, Jiang Y, Peng L, Lin L, Li S, Lv J. Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL‑6/STAT3 signaling pathway. International Journal of Oncology. 59. PMID 34726248 DOI: 10.3892/ijo.2021.5279 |
0.306 |
|
| 2021 |
Wei Z, Zhan X, Ding K, Xu G, Shi W, Ren L, Fang Z, Liu T, Hou X, Zhao J, Li H, Li J, Li Z, Li Q, Lin L, et al. Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock . Frontiers in Pharmacology. 12: 750815. PMID 34721038 DOI: 10.3389/fphar.2021.750815 |
0.349 |
|
| 2021 |
Wang B, Feng W, Wang J, Dong Y, Liu Y, Yao Y, Zhang J, Shi W, Liu L, Zhang H, He X, Chang X, Wang X, Xu H, Liu F, et al. Discovery of potent and selective Bcl-2 inhibitors with acyl sulfonamide skeleton. Bioorganic & Medicinal Chemistry. 47: 116350. PMID 34536651 DOI: 10.1016/j.bmc.2021.116350 |
0.377 |
|
| 2021 |
Shi W, Li J, Zhou J, Li Y, Lin H, Qian H, Fan W. Exploration of novel anti-angiogenic PEDF-derived peptides with improved activitives by inhibiting proliferation, suppressing migration, and inducing 67LR internalization. Bioorganic Chemistry. 116: 105323. PMID 34482170 DOI: 10.1016/j.bioorg.2021.105323 |
0.331 |
|
| 2021 |
Wang Y, Shi W, Wu C, Wan L, Zhao Y, Zhang C, Gu W, Wang S. Pyrazole ring-containing isolongifolanone derivatives as potential CDK2 inhibitors: Evaluation of anticancer activity and investigation of action mechanism. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 139: 111663. PMID 34243605 DOI: 10.1016/j.biopha.2021.111663 |
0.311 |
|
| 2021 |
Zhou C, Zhang Y, Chen J, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Tian J, Ye Z, Wu Q, Qin X, Jiang J, Hou FF, et al. Association between serum advanced oxidation protein products and mortality risk in maintenance hemodialysis patients. Journal of Translational Medicine. 19: 284. PMID 34193178 DOI: 10.1186/s12967-021-02960-w |
0.351 |
|
| 2021 |
Qin Q, Xu G, Zhan X, Wang Z, Wang Y, Liu H, Hou X, Shi W, Ma J, Bai Z, Xiao X. Brevilin A inhibits NLRP3 inflammasome activation in vivo and in vitro by acting on the upstream of NLRP3-induced ASC oligomerization. Molecular Immunology. 135: 116-126. PMID 33892379 DOI: 10.1016/j.molimm.2021.03.025 |
0.332 |
|
| 2021 |
Feng Z, Chen A, Shi J, Zhou D, Shi W, Qiu Q, Liu X, Huang W, Li J, Qian H, Zhang W. Design, synthesis, and biological activity evaluation of a series of novel sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia. Bioorganic Chemistry. 111: 104849. PMID 33798846 DOI: 10.1016/j.bioorg.2021.104849 |
0.379 |
|
| 2021 |
Li J, Zhang W, Qiu Q, Zhou D, Feng Z, Tong Z, Wei J, Huang W, Li J, Qian H, Shi W. Design, synthesis and biological evaluation of novel 4,4-difluoro-1-methyl-N, 6-diphenyl-5, 6-dihydro-4H-pyrimido [4, 5-b] [1, 2, 4] triazolo [4, 3-d] [1, 4] diazepin-8-amine derivatives as potential BRD4 inhibitors. Chemical Biology & Drug Design. PMID 33638254 DOI: 10.1111/cbdd.13833 |
0.336 |
|
| 2021 |
Jiang J, Zhang Y, Chen J, Yang X, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Zhang P, Zhang Y, Zhang Y, Liu S, Zhang Z, et al. Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis. American Journal of Nephrology. 1-9. PMID 33596571 DOI: 10.1159/000512385 |
0.346 |
|
| 2020 |
Liu H, Zhan X, Xu G, Wang Z, Li R, Wang Y, Qin Q, Shi W, Hou X, Yang R, Wang J, Xiaohe X, Bai Z. Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases. Pharmacological Research. 105384. PMID 33352229 DOI: 10.1016/j.phrs.2020.105384 |
0.303 |
|
| 2020 |
Xu G, Fu S, Zhan X, Wang Z, Zhang P, Shi W, Qin N, Chen Y, Wang C, Niu M, Guo Y, Wang JB, Bai Z, Xiao X. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. Jci Insight. PMID 33350984 DOI: 10.1172/jci.insight.134601 |
0.321 |
|
| 2020 |
Zong G, Hu Z, Duah KB, Andrews LE, Zhou J, O'Keefe S, Whisenhunt L, Shim JS, Du Y, High S, Shi WQ. Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F. The Journal of Organic Chemistry. PMID 33264019 DOI: 10.1021/acs.joc.0c01659 |
0.546 |
|
| 2020 |
Li Y, Pasunooti KK, Peng H, Li RJ, Shi WQ, Liu W, Cheng Z, Head SA, Liu JO. Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis Inhibitors. Acs Medicinal Chemistry Letters. 11: 1111-1117. PMID 32550989 DOI: 10.1021/Acsmedchemlett.9B00438 |
0.73 |
|
| 2020 |
Shi W, Xu G, Zhan X, Gao Y, Wang Z, Fu S, Qin N, Hou X, Ai Y, Wang C, He T, Liu H, Chen Y, Liu Y, Wang J, et al. Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases. Cell Death & Disease. 11: 252. PMID 32312957 DOI: 10.1038/s41419-020-2460-x |
0.355 |
|
| 2019 |
Ren J, Shi W, Zhao D, Wang Q, Chang X, He X, Wang X, Gao Y, Lu P, Zhang X, Xu H, Zhang Y. Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitors. Bioorganic & Medicinal Chemistry. 115236. PMID 31843459 DOI: 10.1016/j.bmc.2019.115236 |
0.315 |
|
| 2019 |
Bi X, Li J, Li J, Shi W, Dai Y, Li Q, Zhang W, Huang W, Qian H, Jiang C. Design, synthesis and biological evaluation of novel 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as potential BRD4 inhibitors. Bioorganic & Medicinal Chemistry. PMID 31079968 DOI: 10.1016/j.bmc.2019.05.006 |
0.366 |
|
| 2018 |
Kearney SE, Zahoránszky-Kőhalmi G, Brimacombe KR, Henderson MJ, Lynch C, Zhao T, Wan KK, Itkin Z, Dillon C, Shen M, Cheff DM, Lee TD, Bougie D, Cheng K, Coussens NP, ... ... Shi W, et al. Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space. Acs Central Science. 4: 1727-1741. PMID 30648156 DOI: 10.1021/Acscentsci.8B00747 |
0.345 |
|
| 2018 |
Zhang Y, Shi W. Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. PMID 30532986 DOI: 10.1139/bcb-2018-0114 |
0.325 |
|
| 2018 |
Li Y, Pasunooti KK, Li RJ, Liu W, Head SA, Shi WQ, Liu JO. Novel Tetrazole-containing Analogs of Itraconazole as Potent Anti-angiogenic Agents with Reduced CYP3A4 Inhibition. Journal of Medicinal Chemistry. PMID 30481027 DOI: 10.1021/Acs.Jmedchem.8B01252 |
0.761 |
|
| 2018 |
Li N, Xu M, Bao N, Shi W, Li Q, Zhang X, Sun J, Chen L. Discovery of novel NO-releasing celastrol derivatives with Hsp90 inhibition and cytotoxic activities. European Journal of Medicinal Chemistry. 160: 1-8. PMID 30316059 DOI: 10.1016/j.ejmech.2018.10.013 |
0.305 |
|
| 2018 |
Bauer L, Ferla S, Head SA, Bhat S, Pasunooti KK, Shi WQ, Albulescu L, Liu JO, Brancale A, van Kuppeveld FJM, Strating JRPM. Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP). Antiviral Research. PMID 29807040 DOI: 10.1016/J.Antiviral.2018.05.010 |
0.795 |
|
| 2017 |
Cai D, Yao Y, Tang Y, Wang Z, Shi W, Huang W, Ding K. A Concise Synthesis of Three Branches Derived from Polysaccharide RN1 and Anti-Pancreatic Cancer Activity Study. Polymers. 9. PMID 30965840 DOI: 10.3390/polym9100536 |
0.316 |
|
| 2017 |
Gu W, Dai Y, Qiang H, Shi W, Liao C, Zhao F, Huang W, Qian H. Discovery of novel 2-substituted-4-(2-fluorophenoxy) pyridine derivatives possessing pyrazolone and triazole moieties as dual c-Met/VEGFR-2 receptor tyrosine kinase inhibitors. Bioorganic Chemistry. 72: 116-122. PMID 28411406 DOI: 10.1016/j.bioorg.2017.04.001 |
0.33 |
|
| 2017 |
Jiang W, Li X, Li T, Wang H, Shi W, Qi P, Li C, Chen J, Bao J, Huang G, Wang Y. Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer. International Journal of Oncology. PMID 28197631 DOI: 10.3892/ijo.2017.3860 |
0.373 |
|
| 2017 |
Head SA, Shi WQ, Yang EJ, Nacev BA, Hong SY, Pasunooti KK, Li RJ, Shim JS, Liu JO. Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and Angiogenesis. Acs Chemical Biology. 12: 174-182. PMID 28103683 DOI: 10.1021/Acschembio.6B00849 |
0.727 |
|
| 2017 |
Mu X, Zhao T, Xu C, Shi W, Geng B, Shen J, Zhang C, Pan J, Yang J, Hu S, Lv Y, Wen H, You Q. Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation. Oncotarget. PMID 28061458 DOI: 10.18632/oncotarget.14485 |
0.322 |
|
| 2016 |
Zou P, Pei JH, Shi W, Chen L. [Anticancer drugs targeting glutathione S-transferase π]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica. 51: 241-7. PMID 29856577 |
0.336 |
|
| 2016 |
Qiang H, Gu W, Huang D, Shi W, Qiu Q, Dai Y, Huang W, Qian H. Design, synthesis and biological evaluation of 4-aminopyrimidine-5-cabaldehyde oximes as dual inhibitors of c-Met and VEGFR-2. Bioorganic & Medicinal Chemistry. PMID 27068889 DOI: 10.1016/j.bmc.2016.03.061 |
0.321 |
|
| 2016 |
Shim JS, Li RJ, Bumpus N, Head S, Pasunooti K, Yang EJ, Lv J, Shi W, Liu JO. Divergence of Anti-angiogenic Activity and Hepatotoxicity of Different Stereoisomers of Itraconazole. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26801248 DOI: 10.1158/1078-0432.Ccr-15-1888 |
0.781 |
|
| 2015 |
Head SA, Shi W, Zhao L, Gorshkov K, Pasunooti K, Chen Y, Deng Z, Li RJ, Shim JS, Tan W, Hartung T, Zhang J, Zhao Y, Colombini M, Liu JO. Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 26655341 DOI: 10.1073/Pnas.1512867112 |
0.774 |
|
| 2015 |
Wang Y, Wang B, Guerram M, Sun L, Shi W, Tian C, Zhu X, Jiang Z, Zhang L. Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio. Oncotarget. 6: 29497-512. PMID 26470595 DOI: 10.18632/oncotarget.4985 |
0.344 |
|
| 2014 |
Yang S, Shi W, Xing D, Zhao Z, Lv F, Yang L, Yang Y, Hu W. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria. European Journal of Medicinal Chemistry. 86: 133-52. PMID 25151577 DOI: 10.1016/j.ejmech.2014.07.106 |
0.314 |
|
| 2014 |
Wang G, Jiang MY, Meng Y, Song HR, Shi W. Cellular mechanisms of a new pyrazinone compound that induces apoptosis in SKOV-3 cells. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 797-802. PMID 24568498 DOI: 10.7314/APJCP.2014.15.2.797 |
0.305 |
|
| 2012 |
Zhou QG, Jiang JP, Wu SJ, Tian JW, Chen JH, Yu XQ, Chen PY, Mei CL, Xiong F, Shi W, Zhou W, Liu XS, Sun SR, Xie D, Liu J, et al. Current pattern of Chinese dialysis units: a cohort study in a representative sample of units. Chinese Medical Journal. 125: 3434-9. PMID 23044302 |
0.397 |
|
| 2012 |
Hou F, Jiang J, Chen J, Yu X, Zhou Q, Chen P, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Xie D, Liu J, Zhang P, et al. China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis. Bmc Nephrology. 13: 94. PMID 22935444 DOI: 10.1186/1471-2369-13-94 |
0.406 |
|
| 2012 |
Jiang J, Chen P, Chen J, Yu X, Xie D, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Zhang P, Yang X, Zhang Y, Zhang Y, et al. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis. Atherosclerosis. 224: 187-94. PMID 22857897 DOI: 10.1016/j.atherosclerosis.2012.06.022 |
0.36 |
|
| 2012 |
Zhou Q, Wu S, Jiang J, Tian J, Chen J, Yu X, Chen P, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Xie DI, Liu J, et al. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients. Nephrology (Carlton, Vic.). 17: 642-9. PMID 22738256 DOI: 10.1111/j.1440-1797.2012.01640.x |
0.405 |
|
| 2012 |
Mu X, Shi W, Sun L, Li H, Jiang Z, Zhang L. Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation. Molecules (Basel, Switzerland). 17: 6854-68. PMID 22669041 DOI: 10.3390/molecules17066854 |
0.356 |
|
| 2012 |
Shi W, Han X, Yao J, Yang J, Shi Y. Combined effect of histone deacetylase inhibitor suberoylanilide hydroxamic acid and anti-CD20 monoclonal antibody rituximab on mantle cell lymphoma cells apoptosis. Leukemia Research. 36: 749-55. PMID 22475365 DOI: 10.1016/j.leukres.2012.01.027 |
0.302 |
|
| 2012 |
Peng CC, Shi W, Lutz JD, Kunze KL, Liu JO, Nelson WL, Isoherranen N. Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungals. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 426-35. PMID 22106171 DOI: 10.1124/Dmd.111.042739 |
0.42 |
|
| 2011 |
Shi W, Nacev BA, Aftab BT, Head S, Rudin CM, Liu JO. Itraconazole side chain analogues: structure-activity relationship studies for inhibition of endothelial cell proliferation, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, and hedgehog signaling. Journal of Medicinal Chemistry. 54: 7363-74. PMID 21936514 DOI: 10.1021/Jm200944B |
0.813 |
|
| 2011 |
Shi W, Lowary TL. Structure-activity relationships in glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans as DNA binding and potential antitumor agents. Bioorganic & Medicinal Chemistry. 19: 1779-89. PMID 21296580 DOI: 10.1016/J.Bmc.2011.01.014 |
0.349 |
|
| 2011 |
Shi W, Marcus SL, Lowary TL. Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans. Bioorganic & Medicinal Chemistry. 19: 603-12. PMID 21094049 DOI: 10.1016/J.Bmc.2010.10.054 |
0.408 |
|
| 2010 |
Shi W, Nacev BA, Bhat S, Liu JO. Impact of Absolute Stereochemistry on the Antiangiogenic and Antifungal Activities of Itraconazole. Acs Medicinal Chemistry Letters. 1: 155-159. PMID 21892383 DOI: 10.1021/Ml1000068 |
0.791 |
|
| 2010 |
Shi W, Ma H, Duan Y, Aubart K, Fang Y, Zonis R, Yang L, Hu W. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 1060-3. PMID 21185180 DOI: 10.1016/j.bmcl.2010.11.102 |
0.327 |
|
| 2010 |
Shi W, Duan Y, Qian Y, Li M, Yang L, Hu W. Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 3592-5. PMID 20510610 DOI: 10.1016/j.bmcl.2010.04.123 |
0.335 |
|
| 2010 |
Shi W, Marcus SL, Lowary TL. Synthesis and antibacterial activity of aminosugar-functionalized intercalating agents. Carbohydrate Research. 345: 10-22. PMID 19926076 DOI: 10.1016/J.Carres.2009.10.010 |
0.387 |
|
| 2009 |
Shi W, Coleman RS, Lowary TL. Synthesis and DNA-binding affinity studies of glycosylated intercalators designed as functional mimics of the anthracycline antibiotics. Organic & Biomolecular Chemistry. 7: 3709-22. PMID 19707675 DOI: 10.1039/B909153J |
0.316 |
|
| 2007 |
Fan E, Shi W, Lowary TL. Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues. The Journal of Organic Chemistry. 72: 2917-28. PMID 17373847 DOI: 10.1021/Jo062542Q |
0.408 |
|
| 2001 |
Shi W, Qian X, Zhang R, Song G. Synthesis and Quantitative Structure−Activity Relationships of New 2,5-Disubstituted-1,3,4-oxadiazoles Journal of Agricultural and Food Chemistry. 49: 124-130. PMID 11170568 DOI: 10.1021/Jf0007941 |
0.315 |
|
| Show low-probability matches. |